Mirati Therapeutics reported $1.28B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Astellas Pharma 4503:JP Y 868715M 3873M
AstraZeneca AZN:LN 27.27B 8.54B
Bayer BAYN:GR 32.45B 3.35B
Bluebird Bio BLUE:US $ 903.53M 194.01M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Eisai 4523:JP Y 562507M 44163M
Eli Lilly And LLY:US $ 17295.5M 691M
Exelixis EXEL:US $ 1593.25M 158.98M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Johnson & Johnson JNJ:US $ 53769M 1236M
Moderna Inc MRNA:US 10.97B 734M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Novartis NOVN:VX 23.81B 1.61B
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Spectrum Pharmaceuticals SPPI:US $ 165.71M 3.5M
Takeda 4502:JP Y 2476458M 236435M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
YTE INCY:US $ 2620.06M 170.09M